CONCIT PHARMA HOLDING ApS: Financial statements 2022
CVR: 33061374
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
CONCIT PHARMA HOLDING ApS (CVR 33061374) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -27,487 and a net result of DKK -186,796 compared with DKK -1,086,319 the year before. Equity in the 2022 report amounted to DKK 687,836. The solvency ratio was 37.1%.
- Gross Profit
- DKK -27,487
- Profit/Loss
- DKK -186,796
- Equity
- DKK 687,836
- Total Assets
- DKK 1,856,382
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -27 t. | -187 t. | 688 t. | - |
| 2021 | - | -28 t. | -1.1 mio. | 875 t. | - |
| 2020 | - | -38 t. | -18 t. | 3 mio. | - |
| 2019 | - | -173 t. | -479 t. | 6 mio. | - |
| 2018 | - | -84 t. | -66 t. | 6.5 mio. | - |
Official annual report
Keep an eye on CONCIT PHARMA HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
CONCIT PHARMA HOLDING ApS has published its annual report for 2021. Gross profit came to DKK -27,528, and the net result was DKK -1,086,319.
About CONCIT PHARMA HOLDING ApS
CONCIT PHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Jyderup, founded in 2010. The company has been dissolved on 13 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2023, the company reported a gross profit of DKK -31,247 and a net result of DKK -31,768 compared with DKK -186,796 the year before. Equity in the 2023 report amounted to DKK 656,068.